White Paper
The Future of Pharmacovigilance: Integrating AI with Drug Safety Systems
Using AI in PV to enhance safety processes
Mar 26, 2025

IQVIA's approach to AI in pharmacovigilance is centered on leveraging AI-enabled technologies throughout the drug development and manufacturing lifecycle. This white paper delves into the current regulatory landscape, emphasizing the FDA's ongoing efforts to provide guidance and clarity for AI integration in PV. It also outlines the critical steps organizations must take to align people, technology, and processes to build streamlined workflows supported by robust governance structures. Explore how AI-driven workflows can provide end-to-end services designed to address the most critical challenges in PV.

Download the white paper to gain deeper insights into how AI can revolutionize pharmacovigilance and drive innovation in drug safety systems.

Related solutions

Contact Us